Join Post reporters as the Supreme Court hears oral arguments in a case determining access to mifepristone, a key abortion medication that’s used in more than half of the abortions conducted in the U.S.

As abortion access continues to be controlled through a range of state-by-state policies, a ruling in FDA v. Alliance for Hippocratic Medicine could yield one of the most consequential decisions regarding reproductive rights since the court struck down Roe v. Wade in June 2022.

Libby Casey anchors live coverage from The Washington Post newsroom with analysis from James Hohmann and JM Rieger with Rhonda Colvin live from outside the court. Caroline Kitchener and Dan Diamond provide additional reporting. Read more: https://wapo.st/3IODu9l. Subscribe to The Washington Post on YouTube: https://wapo.st/2QOdcqK

Follow us:
Twitter:   / washingtonpost  
Instagram:   / washingtonpost  
Facebook:   / washingtonpost